MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

MDT

81.83

-0.81%↓

VEEV

209.89

-2.67%↓

A

100.29

-2.02%↓

WBA

10.86

-0.18%↓

CHE

562.75

-2.9%↓

Search

Altimmune Inc

Open

4.58 0.44

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.34

Max

4.59

Belangrijke statistieken

By Trading Economics

Inkomsten

-335K

-23M

Verkoop

5K

EPS

-0.33

Winstmarge

-463,600

Werknemers

59

EBITDA

-344K

-23M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+380.44% upside

Dividenden

By Dow Jones

Volgende Winsten

8 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-69M

357M

Vorige openingsprijs

4.14

Vorige sluitingsprijs

4.58

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Altimmune Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 apr 2025, 01:45 UTC

Winsten

Preview -- Barron's

18 apr 2025, 15:57 UTC

Belangrijke Marktbewegers

Eli Lilly CEO Ricks Warns Against Unintentionally Raising Prices as Weight-Loss Pill Nears Market Launch

20 apr 2025, 22:32 UTC

Top Nieuws

Stocks Poised for Lower Open -- Barrons.com

20 apr 2025, 18:43 UTC

Top Nieuws

Chicago Fed's Goolsbee Has a Warning About Independence -- Barrons.com

20 apr 2025, 18:00 UTC

Top Nieuws

Tesla, Alphabet, Verizon, Chipotle, IBM, Boeing, and Many More Stocks to Watch This Week -- Barrons.com

20 apr 2025, 13:00 UTC

Top Nieuws

Airbus Promised a Green Aircraft. That Bet Is Now Unraveling. -- WSJ

20 apr 2025, 06:00 UTC

Top Nieuws

Foreign Stocks Are Beating the U.S. Market. Here's How Much You Should Have in Your Portfolio. -- Barrons.com

20 apr 2025, 03:00 UTC

Top Nieuws

Putin's War Economy Can't Escape Trump's Trade Blitz -- WSJ

20 apr 2025, 02:00 UTC

Top Nieuws

Who Will Pay the Price for Trump's Economic Goals? -- WSJ

19 apr 2025, 02:00 UTC

Top Nieuws

Tomatoes Become One of the First Everyday Casualties of Trade War -- WSJ

19 apr 2025, 02:00 UTC

Top Nieuws

Beijing Stokes Patriotic Fervor and Blames U.S. for Trade War -- WSJ

18 apr 2025, 20:42 UTC

Acquisities, Fusies, Overnames

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18 apr 2025, 20:32 UTC

Top Nieuws

Trump to Replace Acting IRS Commissioner -- 2nd Update

18 apr 2025, 20:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

18 apr 2025, 19:52 UTC

Marktinformatie

Correction to Aluminum Fee Rising Slower Than Forecast Article

18 apr 2025, 19:40 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

18 apr 2025, 19:40 UTC

Marktinformatie

Aluminum Fee Rising Slower Than Forecast From Tariff -- Market Talk

18 apr 2025, 18:51 UTC

Winsten

Netflix Has Made Several Risky Bets. Earnings Show They've Paid Off. -- Barrons.com

18 apr 2025, 18:40 UTC

Acquisities, Fusies, Overnames

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18 apr 2025, 18:29 UTC

Marktinformatie

Shorter Duration Seen as Way to Shield Portfolio From Political Turbulence -- Market Talk

18 apr 2025, 18:21 UTC

Top Nieuws

Ford Halts Shipments of F-150s and Other Models to China -- WSJ

18 apr 2025, 17:31 UTC

Top Nieuws

Trump to Replace Acting IRS Commissioner -- WSJ

18 apr 2025, 17:24 UTC

Acquisities, Fusies, Overnames

Capital One's Discover Takeover Gets the Green Light. The Two Will Create the 6th-Largest U.S. Bank. -- Barrons.com

18 apr 2025, 17:22 UTC

Acquisities, Fusies, Overnames

Capital One's $35 Billion Discover Takeover Clears Final Approvals -- Barrons.com

18 apr 2025, 16:00 UTC

Top Nieuws

Trump's Trade War Threatens One of America's Top Energy Exports -- WSJ

18 apr 2025, 15:53 UTC

Top Nieuws
Acquisities, Fusies, Overnames

Bill Ackman Teases Prospect of Uber, Hertz Partnership -- Update

18 apr 2025, 15:46 UTC

Winsten

Tech's Problems in China Are Getting Worse. These Companies Are Most at Risk. -- Barrons.com

18 apr 2025, 15:10 UTC

Marktinformatie
Winsten

Netflix Momentum Likely To Continue Thanks To Growing Subscriber Base -- Market Talk

18 apr 2025, 14:46 UTC

Winsten

Tech Earnings Have Good News for Chip Stocks, So Far. And 1 Warning. -- Barrons.com

18 apr 2025, 14:24 UTC

Marktinformatie
Winsten

Netflix Still Has Room to Add Subscribers -- Market Talk

Peer Vergelijking

Prijswijziging

Altimmune Inc Prognose

Koersdoel

By TipRanks

380.44% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 21.86 USD  380.44%

Hoogste 28 USD

Laagste 12 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Altimmune Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Technische score

By Trading Central

4.4 / 4.63Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Altimmune Inc

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.